Cxcr4low FLT3/ITD+ Cells Exhibit Enhanced Resistance to the FLT3 Inhibitor Quizartinib Compared to Cxcr4high FLT3/ITD+ Cells By Elevating Runx1 Expression

被引:0
|
作者
Fukuda, Seiji [1 ]
Onishi, Chie [2 ]
Taketani, Takeshi [3 ]
机构
[1] Shimane Univ, Sch Med, Dept Pediat, Dept Clin Nursing, Izumo, Shimane, Japan
[2] Shimane Univ, Shimane Univ Hosp, Clin Res Ctr, Dept Oncol & Hematol,Sch Med, Izumo, Shimane, Japan
[3] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan
关键词
D O I
10.1182/blood-2019-129513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
129513
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia
    N. Colovic
    D. Tomin
    A. Vidovic
    N. Tosic
    H. D. Atkinson
    Milica D. Colovic
    Medical Oncology, 2012, 29 : 260 - 262
  • [22] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    E Chang
    S Ganguly
    T Rajkhowa
    C D Gocke
    M Levis
    H Konig
    Leukemia, 2016, 30 : 1025 - 1032
  • [23] Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1
    Coleman, Daniel J. L.
    Keane, Peter
    Chin, Paulynn S.
    Ames, Luke
    Kellaway, Sophie
    Blair, Helen
    Khan, Naeem
    Griffin, James
    Holmes, Elizabeth
    Maytum, Alexander
    Potluri, Sandeep
    Strate, Lara
    Koscielniak, Kinga
    Raghavan, Manoj
    Bushweller, John
    Heidenreich, Olaf
    Rabbitts, Terry
    Cockerill, Peter N.
    Bonifer, Constanze
    ISCIENCE, 2024, 27 (04)
  • [24] The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
    Chang, E.
    Ganguly, S.
    Rajkhowa, T.
    Gocke, C. D.
    Levis, M.
    Konig, H.
    LEUKEMIA, 2016, 30 (05) : 1025 - 1032
  • [25] Fluvastatin inhibits FLT3 glycosylation in human and murine cells and prolongs survival of mice with FLT3/ITD leukemia
    Williams, Allen B.
    Li, Li
    Bao Nguyen
    Brown, Patrick
    Levis, Mark
    Small, Donald
    BLOOD, 2012, 120 (15) : 3069 - 3079
  • [26] Role of Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Yan, Chengcheng
    Paterson, Andrew J.
    Li, Hui
    Anderson, Nick
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Yang, Jing
    Xie, Min
    Lu, Rui
    Welner, Rob S.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [27] Reduced Chemosensitivity of FLT3/ITD Mutated Cells to Cytarabine and Quizartinib Under Hypoxic Conditions
    Konig, Heiko
    Rogozea, Adriana L.
    Kinnebrew, Garrett H.
    Ivan, Mircea
    BLOOD, 2016, 128 (22)
  • [28] GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
    Xinhua Xiao
    Peihong Wang
    Weina Zhang
    Jiayi Wang
    Mansi Cai
    Hua Jiang
    Yingli Wu
    Huizhuang Shan
    Cancer Cell International, 23
  • [29] Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update
    Hu, Bei
    Vikas, Praveen
    Mohty, Mohamad
    Savani, Bipin N.
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 301 - 315
  • [30] Combination of an Oxindole Derivative with (-)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells
    Alanazi, Jowaher
    Bender, Onur
    Dogan, Rumeysa
    Malik, Jonaid Ahmad
    Atalay, Arzu
    Ali, Taha F. S.
    Beshr, Eman A. M.
    Shawky, Ahmed M.
    Aly, Omar M.
    Alqahtani, Yasir Nasser H.
    Anwar, Sirajudheen
    MOLECULES, 2023, 28 (13):